PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,361 stories, page 742 of 773

Advanced search
🇺🇰Researchnewcastle-hospitals.nhs.ukTier 2 · Direct publisher

£7.4 million investment helps Newcastle Hospitals shape the future of robotic surgery in the NHS - Newcastle Hospitals NHS Foundation Trust

Freeman Hospital NewcastleOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Cell Biology Program | Sloan Kettering Institute

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Cancer Biology & Genetics Program

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Education & Training

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Working When You Have Cancer

Memorial Sloan Kettering Cancer Center (MSK)Original source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

World-Class Cancer Care, No Matter Where You Call Home

Memorial Sloan Kettering Cancer Center (MSK)Original source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Vaccine Targeting KRAS in Pancreatic Cancer Shows Promise

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Targeted Therapy for Thyroid Cancer Helps Save a Young Voice

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

FDA Approves Immunotherapy-Only Approach for Some Rectal Cancers: What Patients Need To Know

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Promising New Results for Melanoma mRNA Vaccine

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

MSK’s Sloan Kettering Institute Celebrates 75 Years of Discovery

Memorial Sloan Kettering Cancer Center (MSK)Original source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

How MSK’s Expertise Treated a Rare Metaplastic Breast Cancer

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

MSK Scientists Find the 'Molecular Switch' That Heals the Gut — And That Colorectal Cancer Hijacks To Spread

Memorial Sloan Kettering Cancer Center (MSK)Original source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

MSK Research Highlights, October 9, 2026

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

MSK Research Highlights, October 22, 2026

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

MSK Clinical Trials: Bringing the Promise of New Medicine to More Patients

Memorial Sloan Kettering Cancer Center (MSK)Original source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Insights About Cachexia, One of Cancer’s Most Common Complications, Hiding in Routine Patient Data

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

In the News

Memorial Sloan Kettering Cancer Center (MSK)Original source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

How To Lower Ovarian Cancer Risk: Remove the Fallopian Tubes

Memorial Sloan Kettering Cancer Center (MSK)Original source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

FDA Approves Daraxonrasib for Pancreatic Cancer: What Patients Need To Know

Memorial Sloan Kettering Cancer Center (MSK)Original source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Gerstner Sloan Kettering Graduate Students Receive 2026-2027 Fellowships

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

FDA Approves Pritelivir To Treat Herpes Infections in Immunocompromised Patients

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Technologies Available for Licensing

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Tangible Materials Available for Licensing

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Office of Entrepreneurship and Commercialization

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

The SEEK™ Advantage

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

MSK’s Expertise & Experience

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

Education & Consulting Services Packages

Memorial Sloan KetteringOriginal source
🇺🇸Researchmskcc.orgTier 2 · Direct publisher

MSK Evidence-based Practice (EBP) Consulting

Memorial Sloan KetteringOriginal source
🇮🇹Industrymolmed.comTier 1 · Company source

Development, transfer and validation of analytical methods for Cell and Gene Therapy products: Learnings & Challenges | molmed

MolMedOriginal source
🇮🇹Industrymolmed.comTier 1 · Company source

Gene and Cell Therapy: Regulatory CMC, Quality Development and Manufacturing | molmed

MolMedOriginal source
🇮🇹Industrymolmed.comTier 1 · Company source

Case Study: MolMed Presents Process Development and Large-Scale CMP Production for Lentiviral (LV) Vectors

MolMedOriginal source
🇮🇹Industrymolmed.comTier 1 · Company source

Virtual Meeting ASGCT 2020 | molmed

MolMedOriginal source
🇮🇹Industrymolmed.comTier 1 · Company source

Cell&Gene Therapy Virtual Symposium 2020 | molmed

MolMedOriginal source
🇮🇹Industrymolmed.comTier 1 · Company source

Offerta pubblica di acquisto volontaria totalitaria sulle azioni ordinarie di MolMed S.p.A. comunicata da AGC Inc. | molmed

MolMedOriginal source
🇮🇹Industrymolmed.comTier 1 · Company source

Sabato 15/2 Riccardo Palmisano ospite alla trasmissione TV "TGR Officina Italia", in onda su RAI3 alle 11.30

MolMedOriginal source
🇮🇹Industrymolmed.comTier 1 · Company source

WSI Wall street Italia - MOLMED, LA NUOVA SFIDA DEL BIOTECH ITALIA\O

MolMedOriginal source
🇮🇹Industrymolmed.comTier 1 · Company source

Riccardo Palmisano, CEO di MolMed, risponde agli utenti di Finanzaonline | molmed

MolMedOriginal source
🇮🇹Industrymolmed.comTier 1 · Company source

Relazioni periodiche di governance | molmed

MolMedOriginal source
🇮🇹Industrymolmed.comTier 1 · Company source

Cellule geneticamente modificate | molmed

MolMedOriginal source
🇺🇸Industrymodernatx.comTier 1 · Company source

Moderna’s commitment to corporate social responsibility

Moderna NewsOriginal source
🇺🇸Industrymodernatx.comTier 1 · Company source

Medical areas of focus & Modalities - Moderna

Moderna NewsOriginal source
🇺🇸Industrymodernatx.comTier 1 · Company source

Science of mRNA - Moderna

Moderna NewsOriginal source
🇺🇸Industrymodernatx.comTier 1 · Company source

Organizations and companies Moderna works with.

Moderna NewsOriginal source
🇺🇸Industrymodernatx.comTier 1 · Company source

Media kit – Moderna

Moderna NewsOriginal source
🇺🇸Industrymodernatx.comTier 1 · Company source

Innovation at Moderna.

Moderna NewsOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

Newsletter Subscribe - Menarini Group

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

Wheelchair basketball: Volpi Rosse Menarini look to young talent for the new season

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

Thirty Years To Remember: The Fair Play Menarini Award Shines At The Teatro Del Maggio Musicale Fiorentino

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

Gan & Lee and Menarini Group Partner to Advance Bofanglutide in Europe

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

News - Menarini Group

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

Menarini Pills of Art - Menarini Group

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

Menarini and Farmindustria - Menarini Group

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

Fair Play Menarini, International Awards 2026

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

Fair Play Menarini - Menarini Group

Menarini GroupOriginal source
🇮🇹Industrymenarini.comTier 1 · Company source

Fair Play Menarini - Menarini Group

Menarini Group (Global)Original source
🇮🇹Industrymenarini.comTier 1 · Company source

EFPIA - We won’t rest campaign - Menarini Group

Menarini GroupOriginal source